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adjudicated using the Virmani classification and PB assessed from histology. OCT had a high sensitivity, but modest specificity (92.9% and 74.6%), for identifying fibrous cap atheroma (FCA).
The reduced specificity for OCT was due to misclassification of plaques with histologically defined pathological intimal thickening (PIT) as FCA (46.1% of the frames with histological PIT were misclassified). PIT lesions misclassified as FCA by OCT had a statistically higher PB than in other OCT frames (median 32.0% versus 13.4%; p<0.0001). Misclassification of PIT lesions by OCT occurred when PB exceeded approximately 20%. Conclusions: Compared with histology, in-vivo OCT classification of FCA had high sensitivity but reduced specificity due to misclassification of PITs with high PB.
Condensed abstract
Advanced coronary atherosclerosis assessed by in-vivo optical coherence tomography (OCT) has not been directly compared with histology. In a porcine model with human-like coronary atherosclerosis we compared in-vivo OCT images with histology in five animals. We found a high sensitivity but modest specificity of OCT in classifying fibrous cap atheroma (FCA). The modest specificity was caused by misclassification of FCA lesions as pathological intimal thickening. The misclassification most frequently occurred when plaque burden exceeded ~20%. Compared with histology, OCT has high sensitivity but modest specificity for identifying FCA. The study suggests that plaque burden should be considered when interpreting OCT images.
Impact on Daily Practice
Optical coherence tomography (OCT) is increasingly used for the evaluation of coronary atherosclerosis. This study suggests that OCT misclassifies advanced fibrous cap atheroma, particularly when plaque burden is high, and suggests that plaque burden should be considered when interpreting OCT images.
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Disclaimer : As a public service to our readership, this article --peer reviewed by the Editors of EuroIntervention -has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal LCx of all pigs at a speed of 20 mm/s during pump injection of iohexol (4-8 mL/s) using the Illumien system and Dragonfly imaging catheters (St Jude, USA). Prior to each pullback, the OCT catheter was imaged in orthogonal views during injection of iodinated contrast to enable reconstruction of the catheter path, which could be combined with the OCT frames to obtain a 3-D reconstruction of the instrumented artery. After the final catheterization procedure, the pigs were sacrificed and the coronary arteries were perfusion-fixed at 100 mmHg for 1 hour followed by immersion fixation for 24 hours using 4% formaldehyde in phosphate buffered saline (VWR, Prolabo, Belgium) to allow histological evaluation of the instrumented artery.
Evaluating plaque type in OCT frames and histology sections
All frames of the OCT pullback (acquired at 200 µm intervals) within the instrumented vessel of each pig were segmented and evaluated for the presence of fibrous cap atheroma (FCA) by three investigators (NP, IDK, and RDS) who were blinded to the histological data. These analyses were performed offline using standard software (St Jude Medical, USA). FCA within OCT frames was characterized using standard criteria. 4 Specifically, FCA was defined as a plaque containing lipid (signal-poor region, with poorly delineated borders, signal drop-off, and little or no signal backscattering) that was covered by a fibrous cap. The lipid needed to subtend an arc greater than 90° and the fibrous cap was classified as the thinnest portion of tissue layer overlying a signal-poor region. 4 For each FCA, the fibrous cap thickness was measured to allow delineation of thin cap fibroatheroma (TCFA; classified as having a cap thickness ≤85 µm) from thick fibrous cap atheroma (ThFCA). 10 In histology, the cap needed to be ≤65 µm. 14 Normal vessel was classified as having a tri-laminar architecture without intimal thickening.
To validate the characterization of FCA within the OCT frames, histological analysis was performed on ~2.5mm vessel segments immediately upstream and downstream of the implanted stent, where flow disturbances were greatest and plaque development most advanced. Those vessel segments downstream of the stent exhibited the most extensive advanced plaque development.
Tissue blocks containing the coronary artery and underlying myocardium were sectioned at a thickness of 3 µm and serially collected to allow assessment of up to ten stains (the sections for each stain were evaluated at 60 µm intervals) over a distance of ~2. including an error propagation analysis have been reported previously. 12 Because plaque type was evaluated in histology sections with a higher longitudinal frequency (60 µm interval between histological sections, which equated to ~105 µm in-vivo) than OCT frames (200 µm interval), the closest histology section to a given OCT frame was used to validate the plaque type classification within that frame.
To examine differences in plaque size between OCT frames correctly identified not to contain a FCA (based on examination of co-registered histology) versus those falsely identified to have a FCA, we computed PB within the co-registered histological sections as the percentage of plaque area to external elastic membrane area. 15 PB could not be computed from the OCT frames due to the limited penetration depth of this imaging modality.
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Statistics
The ability to accurately identify FCA within OCT frames was evaluated by comparison to coregistered histology sections, which is considered the gold-standard. Performance of this classification was quantified by sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio. Statistical comparisons were performed with a one-way ANOVA and p<0.05 was considered statistically significant. All analyses were done in Matlab.
Results
The implanted SMS induced the development of advanced coronary plaques in all pigs. A total of 201 OCT frames from within the diseased vessel segments proximal to the inlet and outlet of the stent over all pigs were segmented and evaluated for the presence of FCA. Histological analysis was performed on these vessel segments, wherein histological sections were evaluated at 60 µm intervals for plaque type using the Virmani classification system 14 and accurately co-registered to the OCT frames to assess the accuracy of OCT-based FCA identification (Figure 1, 2, 3 Figure 5 ).
Discussion
In the present study, we present the first report of direct comparison of in-vivo OCT classified coronary plaque morphology with co-registered histology. We found that OCT was able to classify FCA with a high sensitivity. However, plaques with histopathologic features of PIT and histologic PB exceeding 20% were often misclassified as FCA by OCT, resulting in a modest specificity of invivo OCT for classifying FCA. In this pilot study, the sensitivity for discriminating TCFA was low.
Using standard criteria definition 4 , the sensitivity and specificity for detecting TCFA by ex-vivo OCT has been reported to range between 72-100% from imaging studies of cadaveric human coronary arteries with paired histology. 10, 11, 16 Though the specificity for identification of TCFA in the current study falls within the reported range, the sensitivity was low at 28.6%. This may be attributable to the small number of TCFA lesions in the current study; the error associated with coregistration of the in-vivo OCT frames and corresponding histological sections, particularly given the heterogeneity of plaque type that was observed when it was delineated on a section-to-section basis at 60 µm intervals. Furthermore changes in the dimensions of the plaque resulting from histological processing, such as perfusion fixation and shrinkage of the tissue, affected the appearance of the lesions and increased the error in measurements of cap thickness causing discrepancies between plaque classification by in-vivo imaging and histology particularly when a common set of diagnostic criteria was applied to both modalities. 10, 12 A pooled analysis combining both TCFAs and ThFCAs was performed to evaluate the ability of invivo OCT to classify FCA plaque morphologies, in general. The sensitivity of in-vivo OCT was comparable to previous ex-vivo OCT imaging studies 17 , though the specificity was modest. 17 The latter was due to misclassification of lesions within the OCT frames as FCA, which actually had histological features of PIT. This was particularly problematic in lesions with higher PB. The light sources used in the various OCT systems have reported tissue depth penetration between 1-3.5 mm. 3, 17 Our findings accord with recent publications from other groups. Phipps et al. 9 showed that irrespective of the atherosclerotic lesion composition, an important cause of FCA misclassification by ex-vivo OCT was foam cell accumulation close to the luminal surface and consequent reduced backscatter of light due to their lipid content, which is consistent with our findings (Figures 1, 2, 3 and 4). In line with these observations, Lutter et al. 18 reported that plaque constituents classified by OCT did not correlate well with histological features. Our study extends these findings by showing that PB is an important determinant of misclassification of FCA plaque morphologies by in-vivo
OCT. This may be improved by using multi-modality intracoronary imaging systems which combine OCT and intravascular ultrasound, with the latter enabling evaluation of PB by virtue of better depth penetration. 20 When comparing animal and human studies, important differences should be noted. The coronary lesions encountered in porcine models have developed over months, not decades as in humans. 21 Though the lesions assessed in the present study showed features of advanced atherosclerosis, including necrotic core formation, calcium depositions and neovascularisation, they appeared more cellular than human lesions 21, 22 with foam cells frequently appearing close to the luminal surface in both PIT and FCA lesions (Figures 1,2, 3 and 4) , which may have influenced the results. 
Study Limitations
Two limitations of this study should be considered. First, a small cohort of 5 pigs was studied and human-like FCA developed in only 3 of 5 animals, including TCFA in 2 of 5 animals. Secondly, the animals were only followed for 34 weeks; a longer follow-up period may have resulted in the Disclaimer : As a public service to our readership, this article --peer reviewed by the Editors of EuroIntervention -has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal development of more advanced lesions. However, even with this sample size, the high-resolution analysis provided sufficient power to allow identification of statistically significant associations between OCT-derived vessel wall/plaque features and histology.
12
Conclusions
We present, to the best of our knowledge, the first comparison between in-vivo OCT classification of coronary FCA compared with co-registered histology. We found that in-vivo OCT has a high sensitivity but only a modest specificity for classification of FCA. While these data require confirmation in a larger sample, they may provide important considerations for the clinical interpretation of in-vivo OCT images of coronary atherosclerotic plaques. 
